Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Kriegsmann

Showing results (61-70 of 178) with videos related to

Pageof 18
Sort By:
Cancers|April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for RedefinitionPhilip Baum, Samantha Taber, Stella Erdmann, et al.
Molecular & Cellular Proteomics : MCP|July 31, 2016
Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue SpecimensMark Kriegsmann, Rita Casadonte, Jörg Kriegsmann, et al.
Frontiers in Oncology|June 5, 2023
Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Frontiers in Oncology|December 9, 2022
Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
BMC Cancer|April 27, 2020
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitutionSandra Sauer, Petra Pavel, Anita Schmitt, et al.
British Journal of Cancer|May 31, 2017
Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancerDaniel Kazdal, Alexander Harms, Volker Endris, et al.
International Journal of Oncology|February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinomaMarc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
Oncotarget|June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary siteHarald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
Pageof 18

Showing results (61-70 of 178) with videos related to

Sort By:
Pageof 18
Cancers|April 30, 2021
Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for RedefinitionPhilip Baum, Samantha Taber, Stella Erdmann, et al.
Molecular & Cellular Proteomics : MCP|July 31, 2016
Reliable Entity Subtyping in Non-small Cell Lung Cancer by Matrix-assisted Laser Desorption/Ionization Imaging Mass Spectrometry on Formalin-fixed Paraffin-embedded Tissue SpecimensMark Kriegsmann, Rita Casadonte, Jörg Kriegsmann, et al.
Frontiers in Oncology|June 5, 2023
Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
Frontiers in Oncology|December 9, 2022
Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sectionsKatharina Kriegsmann, Frithjof Lobers, Christiane Zgorzelski, et al.
BMC Cancer|April 27, 2020
Low-dose peripheral blood stem cell graft after high-dose chemotherapy - an evaluation of hematopoietic reconstitutionSandra Sauer, Petra Pavel, Anita Schmitt, et al.
British Journal of Cancer|May 31, 2017
Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancerDaniel Kazdal, Alexander Harms, Volker Endris, et al.
International Journal of Oncology|February 25, 2022
Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinomaMarc A Schneider, Sarah Richtmann, Anna R Gründing, et al.
Frontiers in Oncology|May 7, 2021
Feasibility and Challenges for Sequential Treatments in ALK-Rearranged Non-Small-Cell Lung CancerMei Elsayed, Farastuk Bozorgmehr, Daniel Kazdal, et al.
Diagnostic Pathology|September 13, 2018
Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancerMark Kriegsmann, Katharina Kriegsmann, Alexander Harms, et al.
Oncotarget|June 21, 2016
Molecular driver alterations and their clinical relevance in cancer of unknown primary siteHarald Löffler, Nicole Pfarr, Mark Kriegsmann, et al.
Pageof 18